This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lovrich, S. D. Articles by Schell, R. F. Search for Related Content PubMed PubMed Citation Articles by Lovrich, S. D. Articles by Schell, R. F.

 Previous Article  |  Next Article 

Infect. Immun., Jun 1995, 2113-2119, Vol 63, No. 6
Copyright © 1995, American Society for Microbiology

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection

SD Lovrich, SM Callister, BK DuChateau, LC Lim, J Winfrey, SP Day and RF Schell
Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison, USA.

The ability of vaccination with recombinant OspA from six seroprotective groups of Borrelia burgdorferi sensu lato to induce protection against infection with homologous and other Lyme spirochetes was examined in hamsters. Antisera generated against the OspA proteins of B. burgdorferi sensu stricto S-1-10 and C-1-11 (seroprotective groups 1 and 2, respectively), Borrelia afzelii BV1 (seroprotective group 4), and Borrelia garinii LV4 (seroprotective group 5) were able to kill the homologous spirochete in vitro but not other isolates. Surprisingly, antisera against B. afzelii PKo (seroprotective group 6) and B. burgdorferi sensu lato LV5 (seroprotective group 3) OspA proteins were unable to kill the homologous organism, although LV5 OspA antisera killed the heterologous isolates S-1-10 and LV4. In vivo vaccination studies supported the in vitro findings, confirming that vaccination with a single OspA protein does not provide complete protection against challenge with all Lyme disease spirochetes. In addition, OspA antibodies from some isolates may not protect against the homologous isolate. The induction of protective antibodies against other B. burgdorferi proteins may be necessary to insure a comprehensive Lyme disease vaccine.

This article has been cited by other articles:

• Munson, E. L., Nardelli, D. T., Luk, K. H. K., Remington, M. C., Callister, S. M., Schell, R. F. (2006). Interleukin-6 Promotes Anti-OspA Borreliacidal Antibody Production In Vitro. CVI 13: 19-25 [Abstract] [Full Text]  
• Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F. (2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI 11: 35-41 [Abstract] [Full Text]  
• Remington, M. C., Munson, E. L., Callister, S. M., Molitor, M. L., Christopherson, J. A., DeCoster, D. J., Lovrich, S. D., Schell, R. F. (2001). Interleukin-6 Enhances Production of Anti-OspC Immunoglobulin G2b Borreliacidal Antibody. Infect. Immun. 69: 4268-4275 [Abstract] [Full Text]  
• Munson, E. L., Du Chateau, B. K., Jobe, D. A., Lovrich, S. D., Callister, S. M., Schell, R. F. (2000). Production of Borreliacidal Antibody to Outer Surface Protein A In Vitro and Modulation by Interleukin-4. Infect. Immun. 68: 5496-5501 [Abstract] [Full Text]  
• Callister, S. M., Jobe, D. A., Schell, R. F., Lovrich, S. D., Onheiber, K. L., Korshus, J. B. (2000). Detection of Borreliacidal Antibodies in Dogs after Challenge with Borrelia burgdorferi-Infected Ixodes scapularis Ticks. J. Clin. Microbiol. 38: 3670-3674 [Abstract] [Full Text]  
• Exner, M. M., Wu, X., Blanco, D. R., Miller, J. N., Lovett, M. A. (2000). Protection Elicited by Native Outer Membrane Protein Oms66 (p66) against Host-Adapted Borrelia burgdorferi: Conformational Nature of Bactericidal Epitopes. Infect. Immun. 68: 2647-2654 [Abstract] [Full Text]  
• Thanassi, W. T., Schoen, R. T. (2000). The Lyme Disease Vaccine: Conception, Development, and Implementation. ANN INTERN MED 132: 661-668 [Abstract] [Full Text]  
• Croke, C. L., Munson, E. L., Lovrich, S. D., Christopherson, J. A., Remington, M. C., England, D. M., Callister, S. M., Schell, R. F. (2000). Occurrence of Severe Destructive Lyme Arthritis in Hamsters Vaccinated with Outer Surface Protein A and Challenged with Borrelia burgdorferi. Infect. Immun. 68: 658-663 [Abstract] [Full Text]  
• Barthold, S. W. (1999). Specificity of Infection-Induced Immunity among Borrelia burgdorferi Sensu Lato Species. Infect. Immun. 67: 36-42 [Abstract] [Full Text]  
• Steere, A. C., Sikand, V. K., Meurice, F., Parenti, D. L., Fikrig, E., Schoen, R. T., Nowakowski, J., Schmid, C. H., Laukamp, S., Buscarino, C., Krause, D. S., The Lyme Disease Vaccine Study Group, (1998). Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant. NEJM 339: 209-215 [Abstract] [Full Text]  
• Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., Evans, J., Malawista, S. E., Molloy, P. J., Seidner, A. L., Sabetta, J. R., Simon, H. J., Klempner, M. S., Mays, J., Marks, D. (1998). A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease. NEJM 339: 216-222 [Abstract] [Full Text]  
• Jensen, J. R., Du Chateau, B. K., Munson, E. L., Callister, S. M., Schell, R. F. (1998). Inhibition of the Production of Anti-OspA Borreliacidal Antibody with T Cells from Hamsters Vaccinated against Borrelia burgdorferi. Infect. Immun. 66: 1507-1512 [Abstract] [Full Text]